OptiNose Inc
NASDAQ:OPTN 4:00:00 PM EDT
| Market Cap (Intraday) | 163.97M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $1.28 |
| 50-Day MA | $1.21 |
| 200-Day MA | $1.41 |
OptiNose Inc Stock, NASDAQ:OPTN
1020 Stony Hill Road, Suite 300, Yardley, Pennsylvania 19067
United States of America
Phone: +1.267.364.3500
Number of Employees: 141
Description
OptiNose, Inc. operates as a pharmaceutical company. The firm engages in the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists. Its products include the XHANCE and ONZETRA Xsail. The company was founded by Per Gisle Djupesland and Helena Kyttari Djupesland in October 2000 and is headquartered in Yardley, PA.